kidney disease
The team measured changes in DNA methylation in more than 1,200 patients to create an algorithm to determine kidney function and predict decline.
MultiOmic Health Raises £5M in Seed Funding Extension Round
The UK precision therapeutics discovery startup will use the new funding for a proof of concept in diabetic kidney disease.
Renalytix to Raise $20.3M in Private Placement
The firm intends to allocate money from the sale toward clinical product development, sales and marketing, and corporate support and financing costs.
Renalytix, Partners Launch $10M Consortium to Develop Kidney Disease Drug Response Tests
Renalytix said it will receive about $1 million in consortium funding to oversee commercial translation activities around the tests.
Renalytix Posts $2.9M in Revenue for Fiscal 2022
The kidney disease-focused in vitro diagnostics firm nearly doubled the previous year's revenue and posted a net loss of $45.3 million in the year ending June 30.